Drug Trial Radar · NCT00063323
Maintenance Treatment for Abstinent Smokers
Last checked: Nov 20, 2026Latest source record: Jan 12, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
589
Actual
Start
Aug 2000
Primary completion
Jul 2006
Study completion Jul 2006
Sponsor
- Lead sponsor
- National Institute on Drug Abuse (NIDA)NIH
- Sponsor type
- NIH
- Collaborators
- Research Foundation for Mental Hygiene, Inc.
- First posted
- Jul 1, 2003
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 21 years, up to 75 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine the efficacy and cost-effectiveness of long-term pharmacotherapy (using Zyban and/or nicotine replacement) for reducing the relapse rate associated with stopping smoking.
Conditions
- Tobacco Use Disorder
Interventions
BupropionDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Survival abstinence rate with maintenance treatmentTime frame: 48 weeks after start of treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
New York State Psychiatric Institute
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.